OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
September 01, 2009
The author reviews the major biopharmaceutical markets' activity and predicts how the markets may evolve.
Scientists from DSM and Kaneka discuss various techniques in this roundtable moderated by Patricia Van Arnum.
Quanticate's Commercial Director explains the ins and outs of outsourcing.
In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.
Increase your chances of success in the biggest market in the world.
Belgium is one of the largest centres for pharmaceutical distribution and has the second highest number of pharma exports per capita worldwide.
August 27, 2009
Eastern Europe's pharmaceutical market is forecast to grow at a CAGR of more than 10% to be worth more than $41 billion by 2014, according to a report from companiesandmarkets.com.
Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory affairs; more...
August 21, 2009
Only 43% of European Chief Financial Officers (CFOs) and Chief Information Officers (CIOs) have tried to calculate the impact of outsourcing on their company, and of those that have tried, only 1 in 5 are confident in their sums, according to a study by Cognizant.
August 20, 2009
Also, FDA publishes draft guidances of two ICH Annexes; EMEA sets format for compliance advice; more...